37 related articles for article (PubMed ID: 38714791)
1. Development and validation of a model for predicting upstage in minimally invasive lung adenocarcinoma in Chinese people.
Liao Y; Li Z; Song L; Xue Y; Chen X; Feng G
World J Surg Oncol; 2024 May; 22(1):135. PubMed ID: 38778366
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the necessity of lymph node sampling in lung adenocarcinoma with ground glass opacities.
Li H; Wu Y; Gao S; Zhou Y; Yang R; Wu Y
Surgery; 2024 Jun; ():. PubMed ID: 38879379
[TBL] [Abstract][Full Text] [Related]
3. Sublobectomy and lymph node sampling are adequate for patients with invasive lung adenocarcinoma presenting as pure ground glass nodules.
Wu H; Wu J; Chen X; Lan Z; Chen Q; Hong L; Yan J; Huang S; Chen J; Lin X; Tang Y; Xu H; Qiao G
Clin Respir J; 2024 May; 18(5):e13766. PubMed ID: 38714791
[TBL] [Abstract][Full Text] [Related]
4. European guidelines for the surgical management of pure ground-glass opacities and part-solid nodules: Task Force of the European Association of Cardio-Thoracic Surgery and the European Society of Thoracic Surgeons.
Cardillo G; Petersen RH; Ricciardi S; Patel A; Lodhia JV; Gooseman MR; Brunelli A; Dunning J; Fang W; Gossot D; Licht PB; Lim E; Roessner ED; Scarci M; Milojevic M
Eur J Cardiothorac Surg; 2023 Oct; 64(4):. PubMed ID: 37243746
[No Abstract] [Full Text] [Related]
5. Sublobectomy for stage IA1-2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25.
Qi YF; Qiu ZB; Zhang C; Fu R; Yang XW; Chu XP; Chen ZH; Yang XN; Wu YL; Zhong WZ
Thorac Cancer; 2022 Nov; 13(22):3174-3182. PubMed ID: 36208139
[TBL] [Abstract][Full Text] [Related]
6. Cancer statistics, 2022.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
[TBL] [Abstract][Full Text] [Related]
7. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US.
Ganti AK; Klein AB; Cotarla I; Seal B; Chou E
JAMA Oncol; 2021 Dec; 7(12):1824-1832. PubMed ID: 34673888
[TBL] [Abstract][Full Text] [Related]
8. Pathological high malignant grade is higher risk of recurrence in pN0M0 invasive lung adenocarcinoma, even with small invasive size.
Ito M; Miyata Y; Kushitani K; Kagimoto A; Ueda D; Tsutani Y; Takeshima Y; Okada M
Thorac Cancer; 2021 Dec; 12(23):3141-3149. PubMed ID: 34643053
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Prognosis of Patients With Resected Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung.
Yotsukura M; Asamura H; Motoi N; Kashima J; Yoshida Y; Nakagawa K; Shiraishi K; Kohno T; Yatabe Y; Watanabe SI
J Thorac Oncol; 2021 Aug; 16(8):1312-1320. PubMed ID: 33915249
[TBL] [Abstract][Full Text] [Related]
10. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; D'Amico TA; Dilling TJ; Dowell J; Gettinger S; Gubens MA; Hegde A; Hennon M; Lackner RP; Lanuti M; Leal TA; Lin J; Loo BW; Lovly CM; Martins RG; Massarelli E; Morgensztern D; Ng T; Otterson GA; Patel SP; Riely GJ; Schild SE; Shapiro TA; Singh AP; Stevenson J; Tam A; Yanagawa J; Yang SC; Gregory KM; Hughes M
J Natl Compr Canc Netw; 2021 Mar; 19(3):254-266. PubMed ID: 33668021
[TBL] [Abstract][Full Text] [Related]
11. Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma.
Sun F; Huang Y; Yang X; Zhan C; Xi J; Lin Z; Shi Y; Jiang W; Wang Q
Cancer Imaging; 2020 Dec; 20(1):87. PubMed ID: 33308323
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary nodules.
Au-Yong ITH; Hamilton W; Rawlinson J; Baldwin DR
BMJ; 2020 Oct; 371():m3673. PubMed ID: 33055130
[No Abstract] [Full Text] [Related]
13. Diagnosis of Invasive Lung Adenocarcinoma Based on Chest CT Radiomic Features of Part-Solid Pulmonary Nodules: A Multicenter Study.
Wu G; Woodruff HC; Shen J; Refaee T; Sanduleanu S; Ibrahim A; Leijenaar RTH; Wang R; Xiong J; Bian J; Wu J; Lambin P
Radiology; 2020 Nov; 297(2):451-458. PubMed ID: 32840472
[TBL] [Abstract][Full Text] [Related]
14. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee.
Moreira AL; Ocampo PSS; Xia Y; Zhong H; Russell PA; Minami Y; Cooper WA; Yoshida A; Bubendorf L; Papotti M; Pelosi G; Lopez-Rios F; Kunitoki K; Ferrari-Light D; Sholl LM; Beasley MB; Borczuk A; Botling J; Brambilla E; Chen G; Chou TY; Chung JH; Dacic S; Jain D; Hirsch FR; Hwang D; Lantuejoul S; Lin D; Longshore JW; Motoi N; Noguchi M; Poleri C; Rekhtman N; Tsao MS; Thunnissen E; Travis WD; Yatabe Y; Roden AC; Daigneault JB; Wistuba II; Kerr KM; Pass H; Nicholson AG; Mino-Kenudson M
J Thorac Oncol; 2020 Oct; 15(10):1599-1610. PubMed ID: 32562873
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.
Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Aokage K; Saji H; Watanabe SI;
J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1469-1480. PubMed ID: 32451073
[TBL] [Abstract][Full Text] [Related]
16. CT Characteristics for Predicting Invasiveness in Pulmonary Pure Ground-Glass Nodules.
Chu ZG; Li WJ; Fu BJ; Lv FJ
AJR Am J Roentgenol; 2020 Aug; 215(2):351-358. PubMed ID: 32348187
[No Abstract] [Full Text] [Related]
17. Lymph node assessment in early stage non-small cell lung cancer lymph node dissection or sampling?
Darling GE
Gen Thorac Cardiovasc Surg; 2020 Jul; 68(7):716-724. PubMed ID: 32266699
[TBL] [Abstract][Full Text] [Related]
18. Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction.
Sun Y; Li C; Jin L; Gao P; Zhao W; Ma W; Tan M; Wu W; Duan S; Shan Y; Li M
Eur Radiol; 2020 Jul; 30(7):3650-3659. PubMed ID: 32162003
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
